PharmAthene, Inc.

PharmAthene, Inc.

Sector: Biological Products Except Diagnostic Substances Region: MD, United States


Similar to: BioTime, Inc., ALLENEX AB

PharmAthene, Inc. operates as a biodefense company, which is engaged in the development and commercialization of medical countermeasures against biological and chemical threats. Its product development programs include SparVax, a second generation recombinant protective antigen anthrax vaccine; Valortim, a fully human monoclonal antibody for the prevention and treatment of anthrax infection; and Recombinant BChE, countermeasures for nerve agent poisoning by organophosphorous compounds, including nerve agents and pesticides. The company was founded in March 2001 and is headquartered in Annapolis, MD.

News & Analysis

You may also be interested in: